Supervisory Health Scientist--Evaluation Team Lead
Erin O'Brien is a Supervisory Health Scientist and Evaluation Team Lead. She writes for Psychiatric Times and Warwick Online, covering a wide range of topics related to mental health, research, and medical advancements. Erin's work has also been featured in PROVIDENCE READING OLYMPICS, showcasing her expertise and commitment to informing and educating readers on important health issues.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Erin O'Brien predominantly covers House & Home topics, with a significant focus on deals and promotions. She frequently features promotional deals and product reviews related to health and wellness, mental health, psychiatry, and medical research. To effectively reach out to Erin, consider pitching content related to household products that promote health and wellness or align with mental health themes.
Given her coverage attributes of Promotional Deal (50%) and Review (20%), she may be open to receiving pitches about new products or services in the areas of mental health support, home healthcare devices or innovative household items that contribute positively to overall well-being.
Erin does not have a specific geographic focus but appears interested in content relevant to a broad audience seeking lifestyle improvements within their homes.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Erin O Brien, David Isaksson
University campuses around the world have become the site of tiny tent cities in recent weeks, with student activists protesting the ongoing conflict in Gaza. But why are young people so passionate about Gaza when there are so man conflicts going on in the world?
By: Erin O'Brien
A poster at the 2024 ASCP Annual Meeting shared data from 3 randomized clinical trials on the safety and tolerability of this treatment combination.
By: Erin O'Brien
An analysis presented at the ASCP Annual Meeting explored the safety and tolerability of the treatment for alcohol and tobacco use disorders.
By: Erin O Brien
A poster presented at the 2024 ASCP Annual Meeting discusses the results of a systematic literature review.
By: Erin O'Brien
How effective is this treatment in real-world clinical settings? Experts explore this in a poster presented at the 2024 ASCP Annual Meeting.
A poster presented at the 2024 ASCP Annual Meeting discussed the results of a study on the efficacy and tolerability of the investigational schizophrenia treatment.
By: Erin O Brien
Experts shared the study results in a poster presentation at the 2024 ASCP Annual Meeting.
By: Erin O Brien
Experts shared the study results in a poster presentation at the 2024 ASCP Annual Meeting.
ronstik_AdobeStock This week, Psychiatric Times ® discussed a wide variety of psychiatric issues and industry updates, from updates on lumateperone and psilocybin to an expert guide on tapering benzodiazepines.
By: Ricardo Whitaker, Samuel Sung, Tina Tylek, Gregory Risser, Erin O'Brien, Phoebe Ellin Chua, Thomas Li, Ryan J Petrie, Kara Spiller, Ricardo Whitaker, Samuel Sung, Tina Tylek, Gregory Risser, Erin O'Br
Abstract We took a systems approach to the analysis of macrophage phenotype in regenerative and fibrotic volumetric muscle loss outcomes in
(833) 317-6278 
